Updated: Apr 8, 2024
Based on 7 analysts giving stock ratings to Verve Therapeutics in the past 3 months
Strong Buy
Buy
Hold
Sell
Updated: Apr 8, 2024
The average Verve Therapeutics stock price target is 27.86 with a max estimate of 40.00 and a min estimate of 15.00
Review Verve Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Apr 8, 2024
Strong Buy
Buy
Hold
Sell
Updated: Apr 8, 2024